首页> 外文期刊>Speciality chemicals magazine >Enzymatic production of the key motelukast intermediate
【24h】

Enzymatic production of the key motelukast intermediate

机译:酶法生产关键莫鲁司特中间体

获取原文
获取原文并翻译 | 示例
           

摘要

As this case study shows, investment in the development of optimised enzymes for chiral synthesis can return a number of advantages, including improved yield, higher stereochemical purity and lower cost. Processes can also be made 'green-by-design', reducing the waste burden and simplifying the overall manufacturing operation.rnThe biocatalytic stereoselective reduction of ketones has become well-established, with a number of current examples and may more under development. Now the scope of enzyme-catalysedrnreactions is broadening to include such new chemistries as C=C reduction, reductive amination, transamination, nitrile hydrolysis, nudeophilic epox-ide opening, chiral sulphoxidation, Baeyer-Villiger oxidation and many others.2rnAs we continue to expand the range of enzymatic reactions that can be used at the commercial scale, biocatalysis will become a mainstream approach for chemical synthesis.
机译:如本案例研究所示,投资开发用于手性合成的优化酶可以带来许多优势,包括提高产量,更高的立体化学纯度和更低的成本。还可以通过“绿色设计”来制造工艺,从而减少废物负担并简化整个制造过程。酮的生物催化立体选择性还原已得到广泛认可,目前有许多实例,并且可能还在开发中。现在,酶催化反应的范围正在扩大,包括新的化学方法,例如C = C还原,还原胺化,氨基转移,腈水解,亲核环氧树脂开放,手性硫氧化,拜尔-维利格氧化等。2随着我们继续扩展由于可以在商业规模上使用的各种酶促反应,生物催化将成为化学合成的主流方法。

著录项

  • 来源
    《Speciality chemicals magazine》 |2008年第3期|36-38|共3页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号